SuperworthClimb Bio shares outstanding CLYM
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 76.2M
- On a year earlier
- +12.7%
- more shares
Climb Bio had 76.2M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 12.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 68.2M | +1% |
| FY2024 | 67.2M | +144% |
| FY2023 | 27.5M | +4% |
| FY2022 | 26.4M | +1% |
| FY2021 | 26.2M | +729% |
| FY2020 | 3.2M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 76.2M | +13% | |
| Q1 FY26 | 68.2M | +1% | |
| Q4 FY25 | 68.2M | +1% | |
| Q3 FY25 | 68M | +1% | |
| Q2 FY25 | 67.6M | +123% | |
| Q1 FY25 | 67.5M | +144% | |
| Q4 FY24 | 67.2M | +144% | |
| Q3 FY24 | 67M | +148% | |
| Q2 FY24 | 30.3M | +13% | |
| Q1 FY24 | 27.6M | +4% | |
| Q4 FY23 | 27.5M | +4% | |
| Q3 FY23 | 27.1M | +3% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Climb Bio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.